The aim of the study was to investigate whether an ''inapparent'' coinfection by hepatitis B virus (HBV) in anti-HCV-positive chronic liver disease patients may influence interferon (IFN) response. Fourteen anti-HCV-positive, hepatitis B surface antigen (HBsAg)-negative but serum HBV-DNA-positive pa
Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection
✍ Scribed by A. L. Zignego; R. Fontana; S. Puliti; S. Barbagli; M. Monti; G. Careccia; F. Giannelli; C. Giannini; G. Buzzelli; M. R. Brunetto; F. Bonino; P. Gentilini
- Publisher
- Springer Vienna
- Year
- 1997
- Tongue
- English
- Weight
- 183 KB
- Volume
- 142
- Category
- Article
- ISSN
- 1432-8798
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Interferon induces remission in about 50% of patients with chronic hepatitis C, but it is difficult to predict which patients will respond. Host and viral factors were evaluated for correlation with response to interferon in patients with chronic hepatitis C. Recombinant interferon alph
To investigate the involvement of T-cell response against hepatitis C virus (HCV) antigens in viral clearance after interferon therapy, we measured interleukin-2 (IL-2) production by peripheral mononuclear cells in response to HCV core in patients with chronic hepatitis C. In a cohort of 43 patients
## Abstract Hepatitis C virus (HCV) replication was assessed before and during alpha‐interferon (IFN) treatment in 22 anti‐HCV positive patients with posttransfusion or sporadic chronic hepatitis (CH). Eleven patients were “responders” and 11 patients “non‐responders” to IFN. Thirteen anti‐HCV nega
Frequent coinfection of surface antigen-negative hepatitis B virus (silent HBV) in hepatitis C virus (HCV)-associated chronic liver disease (CLD) has been reported. The clinical and virological significance of silent HBV infection was investigated in 65 patients with HCV-associated CLD who subsequen